Showing 1 - 10 of 119
Can we design universal access to compassion?
Vanich Kittichai, Published on 19/03/2026
» In the midst of a major war with global impacts, including tangible effects here in Thailand, it would seem ill-advised to devote an opinion piece to an incident easily be written off as just another case of tensions running high in Bangkok.
Baht bets rising
Oped, Postbag, Published on 15/12/2025
» Re: "BoT measures to halt rapid baht uptick", (Business, Dec 5).
UN picks rights council members with bad records
Oped, John J Metzler, Published on 23/10/2025
» In a ritual of near-farcical folly, the UN General Assembly has elected 14 new members to join the Geneva-based Human Rights Council on Oct 15.
Behind the smiles
Oped, Postbag, Published on 23/09/2025
» Re: "Govt denies seizing BBC footage", (BP, Sept 19).
Challenging Asean digital sovereignty
Oped, Kavi Chongkittavorn, Published on 16/09/2025
» Members of the Association of Southeast Asian Nations (Asean) are busy finalising a draft of a Digital Economic Framework Agreement (Defa) -- this digital framework is hoped to boost regional bloc intra-trade, attract foreign investment, and transform the grouping into a global digital hub. As the current chair, Malaysia is eager to see the world's first such agreement concluded under its leadership.
Sustaining healthcare in volatile times
Oped, Vitit Muntarbhorn, Published on 18/08/2025
» Health care is pivotal for human well-being. Yet in today's precarious world, it is pressured by diminishing resources, demographic variables, warfare and violence, and environmental degradation. Sustaining health care thus requires insightful planning and implementation, no less for Thailand and the Association of Southeast Asian Nations (Asean) regions.
Curse of casinos
Oped, Postbag, Published on 09/05/2025
» Re: "Senate to invite PM to explain casino-entertainment complex bill", (BP, May 8).
Unite to solve neglected diseases
Oped, Muhammad Radzi Abu Hassan, Published on 29/04/2025
» The successful collaboration between the health ministries of Malaysia and Thailand, industry partners in Egypt and Malaysia, and the Drugs for Neglected Diseases initiative (DNDi) to bring a new hepatitis C antiviral drug -- ravidasvir -- to market in 2022 was an important milestone. For years, a 12-week course of treatment using sofosbuvir cost between $70,000 (2.34 million baht) and $80,000, putting it out of reach for many in the Global South. But ravidasvir -- a safe and effective alternative when combined with sofosbuvir -- costs far less, averaging less than $500 per course.
Sudan's hell of devastation and despair
Oped, John J. Metzler, Published on 24/04/2025
» The Four Horsemen of the Apocalypse are stalking Sudan: brutal civil conflict, widespread devastation, humanitarian disasters, and the displacement of millions of refugees. Now add the Fifth Horseman, the darkness of global indifference.
Protecting the rot
Oped, Postbag, Published on 18/02/2025
» Re: "Corruption still a problem", (Editorial, Feb 15).